Committee for Orphan Medicinal Products (COMP): 9-11 October 2018

• Date:
  Tuesday, 09 October 2018
• Location:
  European Medicines Agency, Amsterdam, the Netherlands

The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases.

Documents

Agenda - COMP agenda of the 9-11 October 2018 meeting

DraftReference Number: EMA/COMP/634073/2018

COMP meeting report on the review of applications for orphan designation: October 2018

Reference Number: EMA/COMP/679187/2018

Minutes of the COMP meeting 9-11 October 2018

AdoptedReference Number: EMA/COMP/701293/2018